vor 6 Jahren

Berlin to go, english edition 2/2015

  • Text
  • Berlin
  • Healthcare
  • Innovative
  • Scientific
  • Pharmaceutical
  • Germany


DISCUSSION INNOVATIONS ARE BORN OF GOOD IDEAS The figures speak for themselves: The healthcare industry in the capital city region is booming and is setting new technological and scientific standards Over 20,000 companies in the healthcare sector are located in Berlin and Brandenburg. Every eighth employee in the region is employed by a company or institution that deals with aspects of healthcare provision or life sciences. It is this unique density of research and healthcare facilities, thanks to national and international industrial enterprises and clinics, that makes the capital city region a top spot as an international HealthCapital. The healthcare industries cluster in Berlin-Brandenburg is driving the location’s development forwards. What implications will demographic change, globalisation effects and the drive towards digitalisation have? How can a community prepared for the future succeed in develop targeted cooperation between experts and establishing sustainable synergies between research, practice and industry? The question of the future of medicine and the healthcare sector is one that touches all of its players, as well as the wider public. The key to a sustainable answer to these types of leading questions lies in networking. Against this background, the regional amalgamation of all areas of the healthcare industries within a cluster of the same name in the capital city area is even more relevant. What is covered by the umbrella brand HealthCapital? “Our vision is to further develop the capital city region into an internationally leading healthcare location” explains Dr. Kai Uwe Bindseil, HealthCapital Cluster Manager at Berlin Partner. “Already today, we are the top location for life sciences in Europe. And we are constantly working on establishing our innovation leadership at a global level too.” The preconditions appear good. In 2015, about 315,000 employees will generate revenues of about EUR 20 billion in over 20,000 companies in the healthcare sector. Berlin-Brandenburg is home to over 130 clinics, 30 pharmaceutical companies, over 230 biotech companies and about 300 medical engineering enterprises. With the richly traditional Charité, the capital city is also the location of the largest university hospital in Europe. The scientific hotspot is further complemented by over 35 major research facilities and universities, as well as nine technology parks with a focus on life sciences. The synergies between the players determine excellence here. “The healthcare industry in the Berlin region stands out due to the superb representation of all individual fields”, emphasizes Dr. Bindseil. “The growing appeal of the HealthCapital is also characterised by an increasing number of players photo: Hilch / 10 BERLIN TO GO

moving into the area, because they are able to transform their ideas into innovations with extremely high speed here. Our market encourages entrepreneurial creativity through outstanding interlinks with the research and scientific institutions at home here.” And the next generation of talent in the healthcare sector is also well catered for. The Berlin region is home to a wide range of courses, from medical computing at Brandenburg University of Applied Sciences and clinical trial management at Beuth University of Applied Sciences Berlin, through to management courses in healthcare and social services at the Berlin School of Economics and Law. In the life sciences segment alone, around 170 courses are available at 19 Berlin and six Brandenburg universities. New to the management body is cluster spokesman Stefan Oelrich, Managing Director of Sanofi-Aventis Deutschland GmbH (see fact sheet on page 38). “Berlin is home to Europe’s largest university hospital and has over 6000 scien tists: With this, we need to generate greater output for innovations. We must improve framework conditions, to allow us to develop the good ideas of Berlin’s researchers into more patents and products. I want to gain sponsors for this in science, industry and politics”, says Oelrich when outlining his aims within the cluster. Working together with Dr. Bindseil, he is responsible for the strategy and programme of the cluster. The leading stimuli coming from Berlin-Brandenburg are the results of a top quality network. When international leaders from science, research, industry, politics and institutions make their way to the Federal Foreign Office for the 7th World Health Summit from the 11th–13th October, the world of health will once again be welcomed as a guest of the HealthCapital. Their findings and insights are eagerly awaited. ih Two platforms at the cutting edge The question of the future of medicine is the focus of the 3rd Health Week in Berlin-Brandenburg, which is set to take place from the 7th–15th October. The event will present the strengths of the region to a wide audience and invites experts from across Germany and around the world to participate in a knowledge exchange. In addition to local events at selected healthcare locations in the region, a public day and the cluster conference of the healthcare industries in Berlin-Brandenburg, the World Health Summit will also be taking place this week, from the 11th–13th October. This year‘s World Health Summit, which is being held under the patronage of German Chancellor Angela Merkel, French President François Hollande and President of the EU Commission Jean-Claude Juncker, will bring together over 1,300 decision-makers from more than 90 countries to discuss the most pressing issues of global healthcare provision from the perspective of research, civil society, politics and industry. The academic backbone of the event – with its top-class participants – is the “M8 Alliance of Academic Health Centres, Universities and National Academies”, of which the Charité – Universitätsmedizin Berlin is also a member as the initiator of the summit. BERLIN TO GO 11

Publications in English

Publikationen auf deutsch